Asset Allocation

As of March 31, 2026.
Type % Net
Cash 0.25%
Stock 64.84%
Bond 34.68%
Convertible 0.00%
Preferred 0.00%
Other 0.23%
View Asset Allocation
Start Trial

Market Capitalization

Large --
Mid --
Small --
No Data Available
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 99.14%    % Emerging Markets: 0.86%    % Unidentified Markets: 0.00%

Americas 91.36%
91.01%
Canada 64.77%
United States 26.24%
0.35%
As of March 31, 2026. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 7.63%
United Kingdom 1.76%
5.87%
Denmark 0.41%
France 2.78%
Germany 0.65%
Ireland 0.44%
Italy 0.04%
Netherlands 1.08%
Spain 0.15%
Sweden 0.10%
Switzerland 0.20%
0.00%
0.00%
Greater Asia 1.01%
Japan 0.22%
0.00%
0.05%
Taiwan 0.05%
0.74%
China 0.47%
India 0.27%
Unidentified Region 0.00%

Bond Credit Quality Exposure

AAA 22.20%
AA 15.81%
A 26.21%
BBB 25.65%
BB 1.24%
B 0.00%
Below B 0.00%
    CCC 0.00%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.48%
Not Available 8.42%
Short Term 0.00%
As of March 31, 2026
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
25.55%
Materials
5.03%
Consumer Discretionary
5.13%
Financials
14.31%
Real Estate
1.09%
Sensitive
27.10%
Communication Services
2.43%
Energy
5.55%
Industrials
7.75%
Information Technology
11.37%
Defensive
11.45%
Consumer Staples
5.24%
Health Care
3.42%
Utilities
2.79%
Not Classified
35.90%
Non Classified Equity
1.64%
Not Classified - Non Equity
34.26%
As of March 31, 2026
View Region Exposure
Start Trial

Bond Sector Exposure

As of March 31, 2026
Type % Net
Government 14.14%
Corporate 55.67%
Securitized 0.00%
Municipal 19.62%
Other 10.57%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
0.29%
Less than 1 Year
0.29%
Intermediate
88.25%
1 to 3 Years
6.90%
3 to 5 Years
9.87%
5 to 10 Years
71.47%
Long Term
11.46%
10 to 20 Years
1.52%
20 to 30 Years
8.83%
Over 30 Years
1.11%
Other
0.00%
As of March 31, 2026
View Bond Maturity Exposure
Start Trial